Duke University Medical Center
Durham, North Carolina, 27708, United States
NCT Number: NCT00734955
Our objective is to develop a novel optical assay system for intra operative assessment of tumor margins in partial mastectomy or mastectomy specimens. Our group has previously shown that optical techniques can effectively discriminate between malignant and non-malignant breast tissues. We have also shown that data collection and processing from a single point on the tissue specimen requires less than 5 seconds. In addition, the technique is easily adaptable to provide sensing depths that are required for breast margin assessment. The goal of the work proposed in this protocol is to test the sensitivity and specificity of an optical assay system developed by our group, for intra operative assessment of breast tumor margins.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Durham, North Carolina, 27708, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Day of procedure
The primary outcome measure of this study is to identify the optical signatures of normal and cancerous tissue.
Duke University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05176860
Breast Cancer, Breast Diseases
Halifax, Nova Scotia, Canada
View Trial DetailsNCT03644186
Breast Cancer, Breast Diseases
Brasschaat, Belgium
View Trial DetailsNCT04579107
Breast Cancer, Breast Diseases
Stockholm, Sweden
View Trial DetailsNCT04943497
Breast Cancer, Breast Diseases
Syktyvkar, Komi, Russia
View Trial Details